Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
321.5 INR | -2.35% | -1.89% | +1.90% |
04/04 | Gufic Biosciences Forms New Wholly-Owned Arm in Dubai | MT |
03/04 | Gufic Biosciences Limited Incorporates Wholly Owned Subsidiary Company in Dubai | CI |
Sales 2022 | 7.79B 93.47M | Sales 2023 | 6.91B 82.85M | Capitalization | 18.09B 217M |
---|---|---|---|---|---|
Net income 2022 | 958M 11.49M | Net income 2023 | 797M 9.56M | EV / Sales 2022 | 3.16 x |
Net Debt 2022 | 528M 6.33M | Net Debt 2023 | 3.06B 36.66M | EV / Sales 2023 | 3.06 x |
P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
22.7
x | Employees | 1,628 |
Yield 2022 |
0.04% | Yield 2023 |
0.05% | Free-Float | 22.34% |
Latest transcript on Gufic Biosciences Limited
1 day | -2.35% | ||
1 week | -1.89% | ||
Current month | -1.64% | ||
1 month | +4.69% | ||
3 months | -3.26% | ||
6 months | +19.10% | ||
Current year | +1.90% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 41 | 25/04/25 | |
Chief Executive Officer | - | 31/99/31 | |
Director of Finance/CFO | - | 29/18/29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 31/99/31 | |
Chief Executive Officer | 41 | 25/04/25 | |
Director/Board Member | 64 | 01/87/01 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 321.5 | -2.35% | 2 584 |
02/24/02 | 329.2 | +0.73% | 4,736 |
30/24/30 | 326.8 | +1.29% | 2,869 |
29/24/29 | 322.7 | -1.53% | 19,660 |
26/24/26 | 327.7 | +2.31% | 6,661 |
Delayed Quote Bombay S.E., May 03, 2024 at 03:30 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+1.90% | 396M | |
+25.57% | 681B | |
+21.85% | 556B | |
-5.16% | 361B | |
+17.11% | 325B | |
+4.71% | 285B | |
+13.45% | 235B | |
+3.64% | 199B | |
-11.17% | 189B | |
-4.06% | 157B |
- Stock Market
- Equities
- GUFICBIO Stock